Samsung Bioepis’ Post

Our VP and Head of U.S. Market Access Thomas M. Newcomer, MBA spoke about why now is the time to engage #biosimilars more into public disclosure as a way to help biosimilars play a role in bringing down healthcare costs. #PassionForHealth #InnovatingAccess  

How often do you think about your eyes? Let us guess—probably not too often. May is #HealthyVisionMonth, we urge you to get your eyes checked, especially if you’re someone that spends a decent amount of time staring at your device screens.

#EarthDay is a time to remember Samsung Bioepis' efforts to reduce its environmental impact and to promote a sustainable future for the earth. Take a look at some of the ways we are going green! 🌎💚

It’s a busy week for our VP Gillian Woollett. Following Festival of Biologics, she will moderate Session 6 at #BIOS24 on April 19 in Amsterdam, where experts will explore the latest developments in #BiosimilarMedicines frameworks worldwide. Don't miss this opportunity to learn from global regulators. https://bit.ly/441X2AL

The Festival of Biologics which brings together experts in biologics and biotech from around the world kicks off today to this Wednesday in San Diego. The event will feature addresses from Samsung Bioepis' VP Gillian Woollett.

How well do you know your #biosimilar experts? Take a guess to find out who has your best interests in mind. 

For this #WorldHealthDay, the theme is #MyHealthMyRight. Since our start, we’ve been working hard to tackle health inequities by #InnovatingAccess for all through #biosimilars. Marking this World Health Day, let’s take a look at how biosimilars could help people have access to treatments. We will continue to build a fairer and healthier world together.

Following our channel, but still not sure what a #biosimilar is? Or you know, but want a refresher? Take a look at these #FastFacts below and get familiar with biosimilars. #PassionForHealth